Novel heterozygous NFKB1 mutation—variable penetrance in a family cohort

Publication: LymphoSign Journal
20 August 2019

Abstract

Background: Common variable immunodeficiency (CVID) is a term used to define a heterogeneous group of patients who commonly have hypogammaglobulinemia and variable degrees of modest T cell dysfunction. Recent advances made in next generation sequencing technologies have accelerated the identification of CVID disease-causing genes, including NFKB1, a component of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway.
Objective: We sought to identify the genetic defect in a 3-generation family of patients with CVID who presented with cytopenias, eczema, and recurrent sinopulmonary infections.
Methods: Whole exome sequencing and Sanger confirmation was performed, and a combination of molecular and cellular techniques used to assess the variant impact on B and T cell function.
Results: A novel heterozygous frameshift mutation in NFKB1, encoding the transcriptional regulator protein p50/p105, was identified. This resulted in c.1584dupG (p.M528fs). We demonstrate that c.1584dupG is a loss-of-function variant, responsible for reduced p105/p50 protein expression in affected individuals as well as variable increased CD21low B cell numbers.
Conclusion: This novel mutation affecting NFKB1 causes a CVID phenotype with variable clinical manifestations. Given the wide spectrum of age in this kindred, this may reflect diversity of phenotype expression, or more probably, age-related expression of typical features.
Statement of novelty: We report here a novel loss-of-function frameshift mutation in NFKB1.

Formats available

You can view the full content in the following formats:

REFERENCES

Arpaia E., Shahar M., Dadi H., Cohen A., and Roifman C.M. 1994. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking Zap-70 kinase. Cell. 76(5):947–958.
Bonizzi G. and Karin M. 2004. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25(6):280–288.
Boztug H., Hirschmugl T., Holter W., Lakatos K., Kager L., Trapin D., Pickl W., Förster-Waldl E., and Boztug K. 2016. NF-κB1 haploinsufficiency causing immunodeficiency and EBV-driven lymphoproliferation. J. Clin. Immunol. 36:533–540.
Dieli-Crimi R., Martínez-Gallo M., Franco-Jarava C., Antolin M., Blasco L., Paramonov I., Semidey M.E., Álvarez Fernández A., Molero X., Velásquez J., Martín-Nalda A., Pujol-Borrell R., and Colobran R. 2018. Th1-skewed profile and excessive production of proinflammatory cytokines in a NFKB1-deficient patient with CVID and severe gastrointestinal manifestations. Clin. Immunol. 195:49–58.
Fliegauf M. and Grimbacher B. 2018. Nuclear factor κB mutations in human subjects: The devil is in the details. J. Allergy Clin. Immunol. 142(4):1062–1065.
Fliegauf M., Bryant V.L., Frede N., Slade C., Woon S.T., Lehnert K., Winzer S., Bulashevska A., Scerri T., Leung E., Jordan A., Keller B., de Vries E., Cao H., Yang F., Schäffer A.A., Warnatz K., Browett P., Douglass J., Ameratunga R.V., van der Meer J.W., and Grimbacher B. 2015. Haploinsufficiency of the NF-κB1 subunit p50 in common variable immunodeficiency. Am. J. Hum. Genet. 97:389–403.
Karin M. and Lin A. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3(3):221–227.
Kaustio M., Haapaniemi E., Göös H., Hautala T., Park G., Syrjänen J., Einarsdottir E., Sahu B., Kilpinen S., Rounioja S., Fogarty C.L., Glumoff V., Kulmala P., Katayama S., Tamene F., Trotta L., Morgunova E., Krjutškov K., Nurmi K., Eklund K., Lagerstedt A., Helminen M., Martelius T., Mustjoki S., Taipale J., Saarela J., Kere J., Varjosalo M., and Seppänen M. 2017. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J. Allergy Clin. Immunol. 140(3):782–796.
Lin L., DeMartino G.N., and Greene W.C. 2000. Cotranslational dimerization of the Rel homology domain of NF-κB1 generates p50–p105 heterodimers and is required for effective p50 production. EMBO J. 19(17):4712–4722.
Lougaris V., Moratto D., Baronio M., Tampella G., van der Meer J.W.M., Badolato R., Fliegauf M., and Plebani A. 2017. Early and late B-cell developmental impairment in nuclear factor kappa B, subunit 1-mutated common variable immunodeficiency disease. J. Allergy Clin. Immunol. 139(1):349–352.e1.
Maffucci P., Filion C.A., Boisson B., Itan Y., Shang L., Casanova J.-L., and Cunningham-Rundles C. 2016. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front. Immunol. 7:220.
Salmerón A., Janzen J., Soneji Y., Bump N., Kamens J., Allen H., and Ley S.C. 2001. Direct phosphorylation of NF-κB1 p105 by the IκB kinase complex on serine 927 is essential for signal-induced p105 proteolysis. J. Biol. Chem. 276(25):22215–22222.
Tuijnenburg P., Lango Allen H., Burns S.O., Greene D., Jansen M.H., Staples E., Stephens J., Carss K.J., Biasci D., Baxendale H., Thomas M., Chandra A., Kiani-Alikhan S., Longhurst H.J., Seneviratne S.L., Oksenhendler E., Simeoni I., de Bree G.J., Tool A.T.J., van Leeuwen E.M.M., Ebberink E.H.T.M., Meijer A.B., Tuna S., Whitehorn D., Brown M., Turro E., Thrasher A.J., Smith K.G.C., Thaventhiran J.E., Kuijpers T.W., and NIHR BioResource-Rare Diseases Consortium. 2018. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. J. Allergy Clin. Immunol. 142(4):1285–1296.
Vallabhapurapu S. and Karin M. 2009. Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27(1):693–733.

Information & Authors

Information

Published In

cover image LymphoSign Journal
LymphoSign Journal
Volume 6Number 3September 2019
Pages: 95 - 105

History

Received: 4 July 2019
Accepted: 8 August 2019
Accepted manuscript online: 20 August 2019

Authors

Affiliations

Amarilla B. Mandola [email protected]
The Division of Immunology and Allergy, Department of Pediatrics, Hospital for Sick Children and the University of Toronto, Toronto, ON
The Canadian Centre for Primary Immunodeficiency and the Jeffrey Modell Research Laboratory for the Diagnosis of Primary Immunodeficiency, Hospital for Sick Children, Toronto, ON
Nigel Sharfe
The Division of Immunology and Allergy, Department of Pediatrics, Hospital for Sick Children and the University of Toronto, Toronto, ON
The Canadian Centre for Primary Immunodeficiency and the Jeffrey Modell Research Laboratory for the Diagnosis of Primary Immunodeficiency, Hospital for Sick Children, Toronto, ON

Metrics & Citations

Metrics

Other Metrics

Citations

Cite As

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

There are no citations for this item

View Options

View options

PDF

View PDF

Full Text

View Full Text

Get Access

Login options

Check if you access through your login credentials or your institution to get full access on this article.

Subscribe

Click on the button below to subscribe to LymphoSign Journal

Purchase options

Purchase this article to get full access to it.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Media

Other

Tables

Share Options

Share

Share the article link

Share on social media